Rovalpituzumab tesirine and DLL3: a new challenge for small-cell lung cancer

Rossi, A

Rossi, A (reprint author), SG Moscati Hosp, Div Med Oncol, I-83100 Avellino, Italy.

LANCET ONCOLOGY, 2017; 18 (1): 3